Both Hopkins and Singapore have much to gain, and so do our patients. In January, we laid the groundwork for a Hopkins presence in Singapore, and we are now building the structure for what will become a medical, research and education hub in this very important part of the world. What makes Hopkins number one is the way it links research and teaching to its dedication to patients, and that is what will make JHS strong too. He cited several reasons for the agreement with Singapore. On a more practical level, Singapore has a very impressive and extensive infrastructure already in place.
Transportation systems are very adequate.
Singapore's per capita income is second only to Japan's for this region, and its citizens tend to be educated. Most importantly, Singapore has expressed a strong commitment to become a regional medical hub and is willing to provide the resources to accomplish this objective. Artificial liver - Design an artificial liver and develop new drug and gene delivery systems for treating liver disorders. Urology - Create a telerobotic operating system to teach laparoscopic procedures and to treat patients with urological disorders. DataWeaver - Design a system to integrate patient information, treatment and clinical progress.